Your browser doesn't support javascript.
loading
Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma.
Wei, Xiaolin; Michelakos, Theodoros; He, Qian; Wang, Xianxing; Chen, Yu; Kontos, Filippos; Wang, Huaizhi; Liu, Xiangde; Liu, Hui; Zheng, Wenjing; Ferrone, Soldano; Zhang, Yun; Ferrone, Cristina R; Li, Xiaowu; Cai, Lei.
Afiliação
  • Wei X; Department of Hepatobiliary Surgery, Shenzhen University General Hospital & Guangdong Provincial Key Laboratory of Regional Immunity and Diseases and Carson International Cancer Shenzhen University General Hospital and Shenzhen University Clinical Medical Academy Center, Shenzhen University, She
  • Michelakos T; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • He Q; Department of Hepatobiliary Surgery, Shenzhen University General Hospital & Guangdong Provincial Key Laboratory of Regional Immunity and Diseases and Carson International Cancer Shenzhen University General Hospital and Shenzhen University Clinical Medical Academy Center, Shenzhen University, She
  • Wang X; Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, People's Republic of China.
  • Chen Y; Department of Digestive Diseases, Shanghai Fourth People's Hospital Affiliated to Tongji University, Shanghai, People's Republic of China.
  • Kontos F; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Wang H; Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, People's Republic of China.
  • Liu X; Department of Hepatobiliary Surgery, Shenzhen University General Hospital & Guangdong Provincial Key Laboratory of Regional Immunity and Diseases and Carson International Cancer Shenzhen University General Hospital and Shenzhen University Clinical Medical Academy Center, Shenzhen University, She
  • Liu H; Department of Hepatobiliary Surgery, Shenzhen University General Hospital & Guangdong Provincial Key Laboratory of Regional Immunity and Diseases and Carson International Cancer Shenzhen University General Hospital and Shenzhen University Clinical Medical Academy Center, Shenzhen University, She
  • Zheng W; Department of Hepatobiliary Surgery, Shenzhen University General Hospital & Guangdong Provincial Key Laboratory of Regional Immunity and Diseases and Carson International Cancer Shenzhen University General Hospital and Shenzhen University Clinical Medical Academy Center, Shenzhen University, She
  • Ferrone S; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Zhang Y; Department of Foreign Languages, Army Medical University, Chongqing, People's Republic of China.
  • Ferrone CR; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Li X; Department of Surgery, Cedar-Sinai Health System, Los Angeles, CA, USA.
  • Cai L; Department of Hepatobiliary Surgery, Shenzhen University General Hospital & Guangdong Provincial Key Laboratory of Regional Immunity and Diseases and Carson International Cancer Shenzhen University General Hospital and Shenzhen University Clinical Medical Academy Center, Shenzhen University, She
Oncologist ; 28(11): e1031-e1042, 2023 Nov 02.
Article em En | MEDLINE | ID: mdl-37159555
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article